We are live on ! Find out more
AA

AQR Arbitrage Portfolio holdings

AUM $6.09B
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.78B
AUM Growth
-$65.9M
Cap. Flow
-$1.1B
Cap. Flow %
-39.55%
Top 10 Hldgs %
16.2%
Holding
1,575
New
503
Increased
22
Reduced
219
Closed
602

Top Buys

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$32.9M
2
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$26.7M
3
COHR
Coherent Inc
COHR
+$24.6M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$23.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$23.3M

Top Sells

Rank Stock Value
1
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$36.2M
2
BMCH
BMC Stock Holdings, Inc
BMCH
+$35.8M
3
NGHC
National General Holdings Corp
NGHC
+$29.7M
4
CHNGU
Change Healthcare Inc. Tangible Equity Units
CHNGU
+$26.3M
5
EV
Eaton Vance Corp.
EV
+$25.2M

Sector Composition

Rank Sector Weight
1 Financials 10.51%
2 Healthcare 6.47%
3 Industrials 4.82%
4 Consumer Discretionary 4.5%
5 Technology 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APSG.WS
826
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$41K ﹤0.01%
+32,223
New +$62.4K
ADOCR
827
DELISTED
Edoc Acquisition Corp. Right
ADOCR
$39K ﹤0.01%
100,000
– –
FPAC.WS
828
DELISTED
Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
FPAC.WS
$39K ﹤0.01%
+35,000
New +$62K
SPFR.WS
829
DELISTED
Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl
SPFR.WS
$39K ﹤0.01%
+20,000
New +$49.6K
SWETW
830
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$36K ﹤0.01%
+66,499
New +$49.6K
BZFDW icon
831
BuzzFeed Inc Warrant
BZFDW
$905K
$35K ﹤0.01%
+44,332
New +$39.2K
ADOCW
832
DELISTED
Edoc Acquisition Corp. Warrant
ADOCW
$35K ﹤0.01%
100,000
– –
BENEW
833
DELISTED
Benessere Capital Acquisition Corp. Warrant
BENEW
$35K ﹤0.01%
+75,000
New +$55.2K
NSTB.WS
834
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$34K ﹤0.01%
+24,799
New +$45.7K
ADEX.WS
835
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$33K ﹤0.01%
+65,999
New +$42.6K
HMCOW
836
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$33K ﹤0.01%
+24,999
New +$51.3K
BENER
837
DELISTED
Benessere Capital Acquisition Corp. Right
BENER
$33K ﹤0.01%
+100,000
New +$37.6K
TMPMW
838
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$33K ﹤0.01%
+33,333
New +$53.9K
CRXTW
839
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$33K ﹤0.01%
+60,000
New +$48K
EDTXW
840
DELISTED
EdtechX Holdings Acquisition Corp. II Warrant
EDTXW
$33K ﹤0.01%
+73,875
New +$62.4K
EPWR.WS
841
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$32K ﹤0.01%
+63,499
New +$40.3K
EACPW
842
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$31K ﹤0.01%
+61,000
New +$35.7K
BLTSW
843
DELISTED
Bright Lights Acquisition Corp. Warrant
BLTSW
$31K ﹤0.01%
+52,499
New +$45.8K
AGCWW
844
DELISTED
Altimeter Growth Corp Warrant
AGCWW
$31K ﹤0.01%
+10,000
New +$45.4K
SABSW icon
845
SAB Biotherapeutics Warrant
SABSW
$73.4K
$30K ﹤0.01%
+50,000
New +$51.9K
HLAHW
846
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
$30K ﹤0.01%
+42,999
New +$34.4K
HTPA.WS
847
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$30K ﹤0.01%
+24,285
New +$41.5K
SCOAW
848
DELISTED
ScION Tech Growth I Warrant
SCOAW
$29K ﹤0.01%
+33,333
New +$48.1K
FVT.WS
849
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$29K ﹤0.01%
+28,179
New +$38.5K
NIRWW
850
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$28K ﹤0.01%
+49,999
New +$44.2K
32 33
34
35 36

Similar funds

JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

AQR Arbitrage's Q1 2021 Portfolio in Review

As of Q1 2021, AQR Arbitrage held 1,575 positions worth $2.78B, down 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AQR Arbitrage withdrew a net $1.1B in Q1 2021, closing 602 positions and reducing 219 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AQR Arbitrage opened a new position in Cantel Medical Corporation worth $33.4M.

  • AQR Arbitrage's largest Q1 2021 buy was Cantel Medical Corporation: 420,838 shares worth $33.4M.
  • AQR Arbitrage added most to PRA Health Sciences, Inc. in Q1 2021, an estimated $23.3M increase.
  • AQR Arbitrage's biggest Q1 2021 reduction was International Flavors & Fragrances Inc. 6.00% Tangible Equity Units, cutting an estimated $12.5M.
  • AQR Arbitrage fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $36.2M.
  • AQR Arbitrage's ten largest holdings make up 16% of its $2.78B portfolio in Q1 2021.
  • AQR Arbitrage opened 503 new positions and closed 602 in Q1 2021.
  • AQR Arbitrage's portfolio value fell 2.3% quarter-over-quarter to $2.78B.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.